Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

Haas, Eric J, Angulo, Frederick J, McLaughlin, John M, Anis, Emilia, Singer, Shepherd R, Khan, Farid, Brooks, Nati, Smaja, Meir +7 more·2021·The Lancet
DOI 10.1016/s0140-6736(21)00947-8

Cited by (1,001)

Items 901–1,000 of 1,001

  1. Asymptomatic infection and disappearance of clinical symptoms of COVID-19 infectors in China 2022–2023: a cross-sectional study
    Kaige Zhang, Xiao-ying Zhong, Xiaodan Fan, Dongdong Yu, Zhuo Chen, Chen Zhao, Xiaoyu Zhang, Zhiyue Guan, Xuxu Wei, Siqi Wan et al. · 2024 · Scientific Reports
  2. Evaluation of the COVID-19 vaccine effectiveness on the outcomes of COVID 19 disease in Iran: a test-negative case-control study
    Fatemeh Khosravi Shadmani, Ghobad Moradi, Mohammadreza Naghipour, Fatemeh Torkaman Asadi, Ali Reza Ahmadi, Alireza Mirahmadizadeh, Ali Akbar Haghdoost, Bita Mesgarpour, Seyed Mohsen Zahraei, Mohammad Mehdi Goya et al. · 2024 · Frontiers in Immunology
  3. Repurposing pharmaceutical excipients as an antiviral agent against SARS-CoV-2
    Manisha Malani, Pm M. Salunke, Shraddha Kulkarni, G. Jain, A. Sheikh, Prashant Kesharwani, Jayabalan Nirmal · 2021 · Journal of Biomaterials Science. Polymer Edition
  4. The SARS-CoV-2 Lambda variant and its neutralisation efficiency following vaccination with Comirnaty, Israel, April to June 2021
    Neta S. Zuckerman, Ital Nemet, Limor Kliker, Nofar Atari, Yaniv Lustig, Efrat Dahan Bucris, Dana Bar-Ilan, Miranda Geva, Reut Sorek‐Abramovich, Chen Weiner et al. · 2021 · Eurosurveillance
  5. Household Secondary Transmission of the Severe Acute Respiratory Syndrome Coronavirus 2 Alpha Variant From a Community Cluster in a Nursery in Japan
    Tatsuki Ikuse, Yuta Aizawa, Yugo Shobukawa, Nobuko Tomiyama, Hitoshi Nakayama, Masako Takahashi, Kensuke Muto, Satoshi Hasegawa, Masashi Takahashi, Miyako Kon et al. · 2022 · The Pediatric Infectious Disease Journal
  6. The Impact of Vaccination Against SARS-CoV-2 Virus on the Outcome of COVID-19 Disease
    Dania Alkhafaji, Reem Al Argan, Salma AlBahrani, Abrar Alwaheed, Safi Ghazi Alqatari, Abdulmohsen H. Al Elq, Waleed Ibrahim Albaker, Marwan Jabr Alwazzeh, Amal S. AlSulaiman, Reem Shehab AlSulaiman et al. · 2022 · Infection and Drug Resistance
  7. Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in Wuhan
    Jin Yang, Libing Ma, Li Guo, Ting Zhang, Zhiwei Leng, Mengmeng Jia, Fangyuan Chen, Weiran Qi, Xingxing Zhang, Qing Wang et al. · 2022 · Respiratory Research
  8. Impact of COVID-19 Infection, Vaccination, and Serological Response in Immune Thrombocytopenic Purpura Patients: A Single-Center Global Analysis
    Cristina Dainese, Federica Valeri, Marco Bardetta, Carola Sella, Annamaria Porreca, Alessandra Valpreda, Fabrizia Pittaluga, Giulio Mengozzi, Benedetto Bruno, Alessandra Borchiellini · 2022 · Biomedicines
  9. Monoclonal Antibodies against SARS-CoV-2 Infection: Results from a Real-Life Study before the Omicron Surge
    Riccardo Scotto, Antonio Riccardo Buonomo, Giulia Zumbo, Antonio Di Fusco, Nunzia Di Palma Esposito, Isabella Di Filippo, Mariano Nobile, Biagio Pinchera, Nicola Schiano Moriello, Riccardo Villari et al. · 2022 · Vaccines
  10. Modern vaccine strategies for emerging zoonotic viruses
    Atif Ahmed, Muhammad Safdar, Samran Sardar, Sahar Yousaf, Fiza Farooq, Ali Raza, Muhammad Shahid, Kausar A. Malik, Samia Afzal · 2022 · Expert Review of Vaccines
  11. The Implementation and Role of Antigen Rapid Test for COVID-19 in Hemodialysis Units
    Jing Qi, Jia Neng Tan, Soh Heng Hui, Neoh Choo Lim, Titus Lau, Sabrina Wong Peixin Haroon · 2022 · International Journal of Environmental Research and Public Health
  12. Three Outbreaks of COVID-19 in a Single Nursing Home over Two Years of the SARS-CoV-2 Pandemic
    Vladan P. Čokić, Zorana Popovska, Olivera Lijeskić, Ljiljana Šabić, Olgica Djurković–Djaković · 2022 · Aging and Disease
  13. Impacts of delta and omicron variants on inactivated SARS‐CoV‐2 vaccine‐induced T cell responses in patients with autoimmune diseases and healthy controls
    Shuyi Wang, Jin Li, Shuang Wang, Yujin Ye, Mengyuan Li, Yihao Liu, Binfeng Chen, Yimei Lai, Liubing Li, Lili Zhuang et al. · 2023 · Clinical and Translational Medicine
  14. Physical Activity, Sedentary Behavior, and Risk of Coronavirus Disease 2019
    Wenjie Ma, Erin Murray, Long H. Nguyen, David A. Drew, Ming Ding, Konrad Hermann Stopsack, Janet Wilson Rich-Edwards, Jaime E. Hart, Jane C. Figueiredo, James Vincent Lacey et al. · 2023 · The American Journal of Medicine
  15. COVID-19 vaccination improved outcomes in the treatment of geriatric hip fractures between December 2020 and January 2022
    Sanjit R. Konda, Ariana T. Meltzer-Bruhn, Garrett W. Esper, Sara Jo Solasz, Abhishek Ganta, Kenneth A. Egol · 2023 · Hip International
  16. Baseline physical activity and the risk of severe illness and mortality from COVID-19: A dose–response meta-analysis
    Junjie Liu, Zhiguang Guo, Songtao Lu · 2023 · Preventive Medicine Reports
  17. Trajectories of Seroprevalence and Neutralizing Activity of Antibodies against SARS-CoV-2 in Southern Switzerland between July 2020 and July 2021: An Ongoing, Prospective Population-Based Cohort Study
    Rebecca Amati, Giovanni Piumatti, Giovanni Franscella, Peter Buttaroni, Anne-Linda Camerini, Laurie Corna, Sara Levati, Marta Fadda, Maddalena Fiordelli, Anna Maria Annoni et al. · 2023 · International Journal of Environmental Research and Public Health
  18. The effect of mixed vaccination rollout strategy: A modelling study
    Nico Stollenwerk, Carlo Delfin S. Estadilla, Javier Mar, Joseba Bidaurrazaga Van-Dierdonck, Oliver Ibarrondo, Rubén Blasco-Aguado, Maíra Aguiar · 2023 · Infectious Disease Modelling
  19. Uncovering Resilience Disparities among Religious Groups in Israel’s Mass COVID-19 Vaccination Drive: Lessons Learned to the Post-COVID Era
    Miriam Sarid, Maya Kalman‐Halevi, Rony Tutian, S. Gilat, Adi Sarid · 2023 · Behavioral Sciences
  20. COVID-19 mortality in two waves of the pandemic in Cali, Colombia, before and during vaccination roll-out
    Carlos Reina, Pablo Roa, Anthony Garcés, Andrés Valencia, Miyerlandi Torres, Alberto Concha-Eastman · 2023 · Revista Panamericana de Salud Pública
  21. Esoteric Beliefs and Opposition to Corona Restrictions in Germany
    Nils B. Weidmann · 2023 · Politische Vierteljahresschrift
  22. Eleven-month SARS-CoV-2 binding antibody decay, and associated factors, among mRNA vaccinees: implications for booster vaccination
    Michael Asamoah-Boaheng, Brian E. Grunau, Scott Haig, Mohammad Ehsanul Karim, Tracy L Kirkham, Pascal M. Lavoie, Sadaf Sediqi, Steven J. Drews, Sheila F. O’Brien, Vilte Barakauskas et al. · 2023 · Access Microbiology
  23. Morality of vaccination: the influence of moral conviction on vaccination decisions
    Verena Aignesberger, Tobias Greitemeyer · 2023 · Ethics & Behavior
  24. Responses to Common Misconceptions Relating to COVID-19 Variant-Adapted mRNA Vaccines
    George C. Kassianos, Pauline MacDonald, Ivan Aloysius, Shanti Pather · 2024 · Vaccines
  25. Risk of encephalitis and meningitis after COVID-19 vaccination in South Korea: a self-controlled case series analysis
    Ju Hwan Kim, Dongwon Yoon, Hwa Yeon Ko, Kyungyeon Jung, Jun‐Sang Sunwoo, Won Chul Shin, Jung‐Ick Byun, Ju‐Young Shin · 2024 · BMC Medicine
  26. Assessing the Impact of Risk Factors on Vaccination Uptake Policy Decisions Using a Bayesian Network (BN) Approach
    Hafiz Waqar Abbas, Zaman Sajid, Uyen Dao · 2024 · Systems
  27. SARS-CoV-2 vaccine effectiveness and clinical outcomes in hemodialysis patients: the NHIS-COVID-19 cohort study in South Korea
    Young‐Ki Lee, Seon A Jeong, Hayne Cho Park, Do Hyoung Kim, Kyung Don Yoo, Hye Eun Yoon, Yang‐Gyun Kim, Ajin Cho · 2024 · Frontiers in Public Health
  28. Tracking vaccine effectiveness in an evolving pandemic, countering misleading hot takes and epidemiologic fallacies
    Jeffrey S. Morris · 2024 · American Journal of Epidemiology
  29. Quantifying the direct and indirect components of COVID-19 vaccine effectiveness during the Delta variant era
    Anna Suomenrinne-Nordvik, Tuija M. Leino, Mikhail Shubin, Kari J. Auranen, Simopekka Vänskä · 2025 · Epidemiology and Infection
  30. Genome diversity of SARS-CoV-2 lineages associated with vaccination breakthrough infections in Addis Ababa, Ethiopia
    Abebe Mengesha Aga, Demise Mulugeta, Atsbeha Gebreegziabxier, Girum Taye Zeleke, Aderajew Mekonnen Girmay, Gutema Bulti Tura, Abaysew Ayele, Ahmed A. Mohammed, Tigist Belete, Tefera Taddele et al. · 2025 · BMC Infectious Diseases
  31. Evaluation of Covid-19 vaccines: Pharmacoepidemiological aspects
    Antoine Pariente, Julien Bezin · 2021 · Therapies
  32. mRNA vaccine effectiveness against asymptomatic severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection over seven months
    Aaron Joseph Tande, Benjamin D. Pollock, Nilay D. Shah, Matthew J. Binnicker, Elie F. Berbari · 2021 · Infection Control and Hospital Epidemiology
  33. Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines
    Sophie Brunner‐Ziegler, Tibor Spath, Gabriela Verena Kornek, Franz König, Bernhard Parschalk, Maximilian Schnetzinger, Robert Paul Straßl, Rebeka Savic, Andrea Foit, Helene Resch et al. · 2021 · Clinical Microbiology and Infection
  34. Messenger ribonucleic acid vaccines for severe acute respiratory syndrome coronavirus-2 – a review
    Christine M. Akamine, Hana M. El Sahly · 2021 · Translational research
  35. Risk Factors and Incidence Rates of Covid-19 Breakthrough Infections in Vaccinated People in General Medicine Practice in Toledo (Spain)
    Turabian Jose Luis · 2022 · Archives of Family Medicine and General Practice
  36. Vaccine effectiveness to protect against moderate or severe disease in COVID cases: A prospective cohort study
    Rajneesh Kumar Joshi, C.G. Muralidharan, Ankur Ahuja, Reema Mukherjee, Sachin Chaurasia, Linto Manjaly, Divyanshi, Avinav Sahoo, Jayesh Dhananjay Gosavi, Alok Thomas · 2022 · Medical Journal Armed Forces India
  37. Decay rate of antiS1/S2 IgG serum levels after 6 months of BNT162b2 vaccination in a cohort of COVID-19-naive and COVID-19-experienced subjects
    Fabio Borgonovo, Carlo Alberto Stangalini, Carmine Tinelli, Chiara Mariani, Davide Mileto, Maria Vittoria Cossu, Laura Abbati, Lara Bilardo, Gloria Gagliardi, Miriam Cutrera et al. · 2022 · Human Vaccines & Immunotherapeutics
  38. Network Analysis of Well-Being Dimensions in Vaccinated and Unvaccinated Samples of University Students from Poland during the Fourth Wave of the COVID-19 Pandemic
    Aleksandra Maria Rogowska, Karolina Chilicka, Dominika Ochnik, Maria Paradowska, Dominika Nowicka, Dawid Bojarski, Maciej Tomasiewicz, Zuzanna Filipowicz, Maksymilian Grabarczyk, Zuzanna Babińska · 2022 · Vaccines
  39. Efficacy and safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive and biological therapy: Prospective observational study
    Martin Wasserbauer, Štěpán Hlava, Milan Trojánek, Jan Šťovíček, Tomáš Milota, Jir̆ı́ Drábek, Petra Koptová, Andrea Cupkova, Dita Pichlerová, Barbora Frýbová et al. · 2022 · PLoS ONE
  40. Impact of Vaccination and Control Measures on the Fatality of COVID-19: An Ecological Study
    Jinlin Tan, Zhilong Wu, Lin Gan, Qianhong Zhong, Yajuan Zhu, Yufen Li, Dingmei Zhang · 2022 · Journal of Epidemiology and Global Health
  41. Changes in Social and Clinical Determinants of COVID-19 Outcomes Achieved by the Vaccination Program: A Nationwide Cohort Study
    Oliver Ibarrondo, Maíra Aguiar, Nico Stollenwerk, Rubén Blasco-Aguado, Igor Larrañaga, Joseba Bidaurrazaga, Carlo Delfin S. Estadilla, Javier Mar · 2022 · International Journal of Environmental Research and Public Health
  42. Recombinant proteins of spike protein of SARS-CoV-2 with the Omicron receptor-binding domain induce production of highly Omicron-specific neutralizing antibodies
    Hyangju Kang, Daniel Kim, Kyungmin Min, Minhee Park, Seok-Hyun Kim, Eun‐Ju Sohn, Bo-Hwa Choi, Inhwan Hwang · 2022 · Clinical and Experimental Vaccine Research
  43. COVID-19 Vaccination: Does It Alter Postoperative Mortality and Morbidity in Hip Fractures?
    Nuthan Jagadeesh, Jabez Gnany, Sachindra Kapadi, Nidhin Koshy, Debbie Shaw · 2022 · Cureus
  44. Higher plasma levels of thymosin-α1 are associated with a lower waning of humoral response after COVID-19 vaccination: an eight months follow-up study in a nursing home
    María del Mar Pozo‐Balado, Ángel Bulnes‐Ramos, Israel Olivas‐Martínez, Vanesa Garrido‐Rodríguez, Carmen Lozano, Ana Isabel Álvarez‐Ríos, Berta Sánchez-Sánchez, Encarnación Sánchez-Bejarano, Isabel Maldonado-Calzado, José Manuel Martín-Lara et al. · 2023 · Immunity & Ageing
  45. Vascular thrombosis after single dose Ad26.COV2.S vaccine in healthcare workers in South Africa: open label, single arm, phase 3B study (Sisonke study)
    Barry Frank Jacobson, Elise Schapkaitz, Azwidihwi Takalani, Pradeep Rowji, Vernon Johan Louw, Jessica Opie, Linda‐Gail Bekker, Nigel Garrett, Ameena Ebrahim Goga, Tarylee Reddy et al. · 2023 · BMJ Medicine
  46. Factors Associated With COVID-19 Non-Vaccination in Switzerland: A Nationwide Study
    Serena Sabatini, Marco Kaufmann, Marta Fadda, Stefano Tancredi, Nazihah Noor, Bernadette W. A. van der Linden, Stéphane Cullati, Irène Frank, Gisela Michel, E Harju et al. · 2023 · International Journal of Public Health
  47. Development of a SARS‐CoV‐2 viral dynamic model for patients with COVID‐19 based on the amount of viral RNA and viral titer
    Daichi Yamaguchi, Ryosuke Shimizu, Ryuji Kubota · 2024 · CPT Pharmacometrics & Systems Pharmacology
  48. Over- and under-estimation of vaccine effectiveness
    Hilla De-Leon, Dvir Aran · 2025 · BMC Medical Research Methodology
  49. What we know and don’t know on SARS-CoV-2 and COVID-19
    Ignacio Silva-Ayarza, Vivienne C. Bachelet · 2021 · Medwave
  50. Re-analyzing the SARS-CoV-2 series using an extended integer-valued time series models: A situational assessment of the COVID-19 in Mauritius
    Ashwinee Devi Soobhug, Homeswaree Jowaheer, Naushad Mamode Khan, Neeshti Reetoo, Kursheed Meethoo-Badulla, Laurent Musango, Célestin C. Kokonendji, Azmi Chutoo, Nawel Aries · 2022 · PLoS ONE
  51. A Clinician’s Obligation to be Vaccinated: Four Arguments that Establish a Duty for Healthcare Professionals to be Vaccinated Against COVID-19
    Johan Christiaan Bester · 2022 · Journal of Bioethical Inquiry
  52. Understanding Covid Vaccine Efficacy over Time — Bridging a Gap Between Public Health and Health Care
    Isaac S. Kohane, Gilbert S. Omenn · 2022 · New England Journal of Medicine
  53. The Evolving Scenario of COVID-19 in Hemodialysis Patients
    Pasquale B. Esposito, Daniela Picciotto, Francesca Cappadona, Elisa Russo, Valeria Falqui, Novella Evelina Conti, Angelica Parodi, Laura Mallia, Sara Cavagnaro, Yuri Battaglia et al. · 2022 · International Journal of Environmental Research and Public Health
  54. Novel deterministic epidemic model considering mass vaccination and lockdown against coronavirus disease 2019 spread in Israel: a numerical study
    Motoaki Utamura, M. Koizumi, Seiichi Kirikami · 2022 · Biology Methods and Protocols
  55. Effectiveness of BNT162b2 mRNA COVID-19 Vaccine Against SARS-CoV-2 Variant Beta (B.1.351) Among Persons Identified Through Contact Tracing in Israel
    Shepherd Roee Singer, Frederick J. Angulo, David L. Swerdlow, John M. McLaughlin, Itay Hazan, Netanel Ginish, Emilia Anis, Ella Mendelson, Orna Mor, Neta S. Zuckerman et al. · 2021 · SSRN Electronic Journal
  56. Development and validation of a questionnaire to measure attitudes toward COVID-19 vaccination and pandemic
    Petros Galanis, Irene Vraka, Olga Siskou, Olympia Konstantakopoulou, Aglaia Katsiroumpa, Ioannis Moisoglou, Daphne Kaitelidou · 2021 · medRxiv
  57. Virtual reality reduces COVID-19 vaccine hesitancy in the wild
    Clara Vandeweerdt, Tiffany Luong, Michael Atchapero, Aske Mottelson, Christian Holz, Guido Makransky, ROBERT M. BOHM · 2021
  58. Different interventions for COVID-19 primary and booster vaccination? Effects of psychological factors and health policies on vaccine uptake
    Philipp Sprengholz, Luca Henkel, ROBERT M. BOHM, Cornelia Betsch · 2022
  59. Letter to Editor “Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs”: Important concerns on the validity of this article
    Jérôme Barrière, Fabrice Frank, Lonni Besançon, Alexander Samuel, Véronique Saada, Eric Billy, Abraham Jacob Al-Ahmad, Nans Florens, Barbara Seitz‐Polski, Jacques Robert · 2023 · Food and Chemical Toxicology
  60. The extent and impact of vaccine status miscategorisation on covid-19 vaccine efficacy studies
    Martin Neil, Scott McLachlan, Norman Fenton · 2024 · medRxiv
  61. Immunogenicity and protective efficacy of the HC009 mRNA vaccine against SARS-CoV-2
    Juan Liu, Huafeng Han, Bin Yang, Naifang Zhang, Jing Li, Xicheng Chen, Jie Wu, Yingying Zhao, Yongsheng Yang · 2024 · Frontiers in Immunology
  62. XBB.1.16‐RBD‐based trimeric protein vaccine can effectively inhibit XBB.1.16‐included XBB subvariant infection
    Dandan Peng, Cai He, Zimin Chen, Hong Lei, Xiya Huang, Chunjun Ye, Binhan Wang, Ying Hao, Xinyi Du, Shuaiyao Lu et al. · 2024 · MedComm
  63. Discrimination of a single-item scale to measure intention to have a COVID-19 vaccine
    Julius Sim, Louise Smith, Richard Amlôt, Gideon James Rubin, Nick Sevdalis, Susan Mary Sherman · 2025 · PLoS ONE
  64. COVID-19 vaccine uptake in a retrospective population-based cohort of people living with and without HIV in Ontario, Canada
    Cassandra Freitas, Curtis Cooper, Abigail E. Kroch, Rahim Moineddin, Gordon Arbess, Anita C. Benoit, Sarah A. Buchan, Catharine Chambers, Muluba Habanyama, Claire Kendall et al. · 2025 · Vaccine
  65. Mortality risk model validation in a prospective cohort of patients from the sixth wave of the COVID-19 pandemic in a hospital emergency department
    Leticia Fresco, Gina I. Osorio, Daniel N. Marco, Lourdes Artajona, Dora Sempertegui, Daniela Piñango, Natalija Demidenoka, Julia García-Gozalbes, Míriam Carbó, Milagrosa Perea et al. · 2024 · Emergencias
  66. Robust specific RBD responses and neutralizing antibodies after ChAdOx1 nCoV-19 and CoronaVac vaccination in SARS-CoV-2– seropositive individuals
    Edgar Ruz Fernandes, Mônica Taminato, Juliana de Souza Apostólico, Maria Cristina Gabrielonni, Victória Alves Santos Lunardelli, Juliana Terzi Maricato, Mônica L. Andersen, Sérgio Tufik, Daniela Santoro Rosa · 2023 · Journal of Allergy and Clinical Immunology Global
  67. Knowledge, Attitude, and Practices Towards COVID-19 Among Social Workers of Bangladesh
    Md. Mostafizur Rahman, Mohammed Sadman Sakib, Afra Sayara Rahman, Md. Iftekharul Haque, Md. Tanvir Hossain, Md. Robiul Islam · 2023 · Public Organization Review
  68. Analysis of Factors Influencing the Clinical Severity of Omicron and Delta Variants
    Shanlu Zhao, Kaiwei Luo, Yichao Guo, Mingli Fang, Qianlai Sun, Zhihui Dai, Hao Yang, Zhifei Zhan, Shixiong Hu, Tianmu Chen et al. · 2023 · Tropical Medicine and Infectious Disease
  69. SARS-CoV-2 spike protein-derived immunogenic peptides that are promiscuously presented by several HLA-class II molecules and their potential for inducing acquired immunity
    Yuki Yajima, Akemi Kosaka, Takayuki Ohkuri, Yoshihiko Hirohashi, Dongliang Li, Takeshi Nagasaki, Toshihiro Nagato, Toshihiko Torigoe, Hiroya Kobayashi · 2023 · Heliyon
  70. Effectiveness of the Original COVID-19 Vaccine against COVID-19 Exacerbations during the Omicron Wave: A Population-based Study in Okayama, Japan
    Naomi Matsumoto, Toshiharu Mitsuhashi, Rumi Matsuo, Tomoka Kadowaki, Soshi Takao, Takashi Yorifuji · 2023 · JMA Journal
  71. Comparison of Post-Vaccination Response between mRNA and Vector Vaccines against SARS-CoV-2 in Terms of Humoral Response after Six Months of Observation
    Sebastian Słomka, Patrycja Zięba, Oskar Rosiak, Anna Piekarska · 2023 · Vaccines
  72. The humoral response to COVID-19 vaccinations can predict the booster effect on health care workers—toward personalized vaccinations?
    Ophir Freund, Alma Harish, Anna Breslavsky, Ori Wand, Nadav Zacks, Natalya Bilenko, Amir Bar‐Shai · 2023 · Journal of Public Health
  73. Vaccine effectiveness of COVID-19 and rebound in the real world
    Myung-Bae Park, Boram Sim · 2023 · Clinical and Experimental Medicine
  74. Inducing enhanced neutralizing antibodies against broad SARS-CoV-2 variants through glycan-shielding multiple non-neutralizing epitopes of RBD
    Qingyun Zhang, Yi Yang, Jun Lan, Ziyi Wang, Yan Gao, Xiao Li, Weidong Mao, Jing Xie, Li-Zhi Mi, Xiangyang Zhang et al. · 2023 · Frontiers in Immunology
  75. Protection of prior SARS-CoV-2 infection, COVID-19 boosters, and hybrid immunity against Omicron severe illness: A population-based cohort study of five million residents in Canada
    Shishi Wu, Yanhong Li, Stefan Baral, Sharmistha Mishra, Maria Koh, Haley Golding, Jeffrey C. Kwong, Xiaolin Wei · 2024 · PLoS ONE
  76. The Predictive Value of Gut Microbiota Composition for Sustained Immunogenicity following Two Doses of CoronaVac
    Ho Yu Ng, Yunshi Liao, Ruiqi Zhang, Kwok‐Hung Chan, Elvis Wai-Pan To, Chun-Him Hui, Wai‐Kay Seto, Wai K. Leung, Ivan Fan‐Ngai Hung, Tommy Tsan‐Yuk Lam et al. · 2024 · International Journal of Molecular Sciences
  77. Vaccination strategies impact the probability of outbreak extinction: A case study of COVID-19 transmission
    Natcha C. Jitsuk, Sudarat Chadsuthi, Charin Modchang · 2024 · Heliyon
  78. Cost effectiveness analysis comparing varying booster intervals of vaccination policies to address COVID-19 situation in Thailand, 2023
    Chayanit Mahasing, Rapeepong Suphanchaimat, Pard Teekasap, Natthaprang Nittayasoot, Suphanat Wongsanuphat, Panithee Thammawijaya · 2024 · PLoS ONE
  79. Evolutionary dynamics of voluntary vaccination for imperfect multi-efficacy vaccines
    Shusheng Hu, Yuan Liu, Bin Wu · 2024 · Proceedings of the Royal Society A Mathematical Physical and Engineering Sciences
  80. Evaluation of BBIBP-CorV Sinopharm COVID-19 vaccine effectiveness in Sri Lanka: a test-negative case control study
    Shamila De Silva, Dileepa Senajith Ediriweera, Wathsala Wimalasena, Manjula Kariyawasam, Gihan Kosinna, Gayan Bogoda, Sumudu Senaratne, Kanchana Rathnayake, Inosha Weerarathna, R. Premaratna et al. · 2024 · BMJ Open
  81. AI Predictive Model of Mortality and Intensive Care Unit Admission in the COVID-19 Pandemic: Retrospective Population Cohort Study of 12,000 Patients
    José Manuel Ruiz‐Giardín, Óscar Garnica, Nieves Mesa Plaza, Juan Víctor SanMartín López, Ana Isabel Farfán‐Sedano, Elena Madroñal Cerezo, Miguel Ángel Duarte‐Millán, Aida Izquierdo-Martínez, Luis Rivas, Marta Rivilla et al. · 2025 · Journal of Medical Internet Research
  82. Words are not just words: how the use of media language in the COVID-19 era affects public health
    Georgios P. Georgiou · 2021 · Epidemiology and Health
  83. Immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in elderly people over 85 years of age in Greece: the GREVAXIMO study
    Κωνσταντίνα Κοντοπούλου, Christos Theodoros Nakas, Alexandra Ainatzoglou, Athina M. Ifantidou, Paschalina Ntotsi, Christos Katsioulis, Georgios Papazisis · 2021 · Aging Clinical and Experimental Research
  84. Interaction between Spike Protein of SARS-CoV-2 and Human Virus Receptor ACE2 Using Two-Color Fluorescence Cross-Correlation Spectroscopy
    Ai Fujimoto, Yidan Lyu, Masataka Kinjo, Akira Kitamura · 2021 · Applied Sciences
  85. Métodos para avaliação da efetividade de vacinas para COVID-19 com ênfase em abordagens quase-experimentais
    Júlia Moreira Pescarini, Camila Silveira Silva Teixeira, Enny S. Paixão, Naiá Ortelan, Priscila Fernanda Porto Scaff Pinto, Andrêa Jacqueline Fortes Ferreira, Flávia Jôse Oliveira Alves, Elzo Pereira Pinto, Ila Rocha Falcão, Aline dos Santos Rocha et al. · 2021 · Ciência & Saúde Coletiva
  86. A Retrospective Cross-Sectional Study of Severe Breakthrough SARS-CoV-2 Infection in the General Population Requiring Hospitalization Within a Single Health System
    Roshan Acharya, Smita Kafle, NATALIE N KANDINATA, Brian Slipman, Meera Ghimire, Andrew B. Trotter · 2022 · Journal of Clinical Medicine Research
  87. Screening Large Population Health Databases for Potential Coronavirus Disease 2019 Therapeutics: A Pharmacopeia-Wide Association Study of Commonly Prescribed Medications
    Derek R. MacFadden, Kevin Antoine Brown, Sarah A. Buchan, Hannah Chung, Rob Kozak, Jeffrey C. Kwong, Douglas G. Manuel, Samira Mubareka, Nick Daneman · 2022 · Open Forum Infectious Diseases
  88. Coronavirus vaccination rates in cultural areas in Germany
    Claudia Spahn, Anna Maria Hipp, Bernhard Richter, Manfred Nusseck · 2022 · Epidemiology and Infection
  89. Timing of surgery and elective perioperative management of patients with previous SARS-CoV-2 infection: a SIAARTI expert consensus statement
    Andrea Cortegiani, Vincenzo Francesco Tripodi, Carlo Alberto Castioni, Clelia Esposito, Nicola Galdieri, Roberta Monzani, Marco Rispoli, Alessandro Simonini, Vito Torrano, Antonino Giarratano et al. · 2022 · Journal of Anesthesia Analgesia and Critical Care
  90. Receiving COVID-19 vaccine, hospitalization, and outcomes of patients with COVID-19: A prospective study
    Deldar Morad Abdulah, Abbas Muhammed Sadiq Mirza · 2022 · Monaldi Archives for Chest Disease
  91. SARS-CoV-2 vaccination willingness and predictors in patients with chronic inflammatory rheumatic diseases (CIRD) and without CIRD
    Iulia Roman, Ioana Andreica, Xenofon Baraliakos, Imke Redeker, Uta Kiltz, Jürgen Braun · 2022 · Therapeutic Advances in Musculoskeletal Disease
  92. New onset of acute uveitis following COVID-19 vaccination
    Ha Eun Sim, Je Hyung Hwang · 2022 · Graefe s Archive for Clinical and Experimental Ophthalmology
  93. Measuring the impact of COVID-19
    Kaelyn F Burns, Jennifer A. Horney · 2022 · Elsevier eBooks
  94. Reduced Risk of Progression from Non-Severe to Severe COVID-19 in Hospitalized Dialysis Patients by Full COVID-19 Vaccination
    Mitsuru Ichii, Masafumi Kurajoh, Yujiro Okute, Yasutaka Ihara, Takumi Imai, Tomoaki Morioka, Katsuhito Mori, Tetsuo Shoji, Yoshihiro Tsujimoto, Takanobu Ubai et al. · 2022 · Journal of Clinical Medicine
  95. Cambios en las características clínicas y desenlaces de pacientes hospitalizados por COVID-19 durante dos años de pandemia: experiencia en un hospital venezolano
    María Cristina Arvelo, María Montes de, Laura Sánchez-Traslaviña, Flor Helene Pujol, Rossana Celeste Jaspe, Isabel C. Silva, Irene Stulin, Gabriela Blanco, Jennireth Quevedo, Nathalia Valera et al. · 2022 · Revista Peruana de Medicina Experimental y Salud Pública
  96. Does public health policy quality foster state innovation capacity? Evidence from a global panel data
    Xiaoyi Ji, Ling Gao, Huan Liu, Shengyu He, Baoqing Zhu, Cheng Chow, Jieqiong Chen, Zhipeng Lu, Li Li · 2022 · Frontiers in Public Health
  97. COVID-19 vaccination benefits in preventing severe disease in mild-to-moderate cases: An analysis in the first specialized hospital for COVID-19 in Japan
    Masanori Kobayashi, Atsushi Miyamoto, Tetsuya Watanabe, Kenji Sawa, Kanako Sato, Kazuhiro Yamada, Naoko Yoshii, Koichi Yamada, Kengo Kawamoto, Masato Uji et al. · 2023 · Respiratory Investigation
  98. Rapidly Establishing an Ultra-Cold Supply Chain of Vaccines in Israel: Evidence for the Efficacy of Inoculation to Mitigate the COVID-19 Pandemic
    Michael Naor, Gavriel David Pinto, Pini Davidov, Lina Abdrbo · 2023 · Vaccines
  99. Effect of Moderate to Severe Hepatic Steatosis on Vaccine Immunogenicity against Wild-Type and Mutant Virus and COVID-19 Infection among BNT162b2 Recipients
    Ka Shing Cheung, Lok Ka Lam, Xianhua Mao, Jing Tong Tan, Poh Hwa Ooi, Ruiqi Zhang, Kwok Hung Chan, Ivan Fan‐Ngai Hung, Wai‐Kay Seto, Man‐Fung Yuen · 2023 · Vaccines
  100. Comparison of the effectiveness of four SARS-COV-2 v accines in Nuevo Leon, Mexico: A test-negative control study
    Ana Marı́a Salinas-Martı́nez, Edgar Paolo Rodríguez Vidales, Denise Garza‐Carrillo, Olivia A. Robles‐Rodríguez, Roberto Montes‐de‐Oca‐Luna, Alma Rosa Marroquín-Escamilla · 2023 · Atención Primaria